Friday, February 23, 2018

UPDATE – Friday, February 23, 2018 (6:30 p.m.)


At 4 p.m. today, Middlesex Hospital began providing emergency care to walk-in patients. The Hospital opened a temporary Emergency Department space in its outpatient surgical services area.

It is still not receiving patients via ambulance, and the Hospital’s normal Emergency Department
location in Middletown is still closed until further notice.

Patients who visit the Hospital’s temporary Emergency Department space should drive to the main
entrance of the Hospital. At that point, a security officer will be there to greet them. The officer will
then direct them to where they need to go.

If someone is sick or injured and needs immediate attention, they should call 9-1-1. An ambulance will bring them to the next nearest emergency department. Middlesex’s other Emergency Department locations in Westbrook and Marlborough are open.

Non-emergent surgeries are canceled for today, Friday, February 23.

Radiology is up and running at the Hospital. However, all outpatient radiology tests are canceled at the Hospital in Middletown today, Friday, February 23.

Patients can get lab tests at the Outpatient Center, 534 Saybrook Road in Middletown; at the Marlborough Medical Center in Marlborough; or at the Shoreline Medical Center in Westbrook. However, they should not come to the Hospital.

Patients are now allowed to receive visitors. Flu restrictions remain in place.

All other Middlesex Health System locations are operating as normal.

Gene Testing for Breast or Ovarian Cancer

At Middlesex Hospital, we’re not satisfied with simply diagnosing and treating cancer. Our goal is to use the latest technology to identify those who may be most susceptible, and then help them reduce their risks before the first cancer cells even have a chance to develop.

Our breast cancer gene testing program uses DNA analysis to look for alterations in either of the two “breast cancer genes,” known as BRCA1 and BRCA2 the most common cause of hereditary breast and ovarian cancers. Although these alterations are uncommon—they’re only responsible for about 5% of breast cancers and 15% of ovarian cancers—women who have inherited them face a much higher risk of developing breast or ovarian cancer during their lifetimes.  In addition, our breast cancer gene testing program uses DNA panel genetic testing to look for alterations in other genes associated with an increased risk for breast cancer, for example TP53, ATM, CHEK2, PALB2, BRIP1 and others.

If you are a candidate for genetic testing, this simple blood test will let you know if you do have a gene alteration associated with increased risk for breast cancer. Then, based on your results, a genetic counselor will be able to provide you with an estimate of your risk for breast or ovarian cancer.

Sign Up for our Monthly e-Newsletter

Confirm Your Information

28 Crescent Street
Middletown, CT 06457

Copyright © 2018   All Rights Reserved.